Mental health has moved from the margins to the center of the global healthcare conversation. Rising anxiety, depression, and ...

A small company can now advance its psychedelic into phase 3. Here’s why that matters to other psychedelic biotechs. A small ...

Jason Najum covers the psychedelic space and contextualizes recent news around the FDA, MDMA, PTSD, and Lykos Therapeutics. Why it may be a blessing in disguise for Cybin, COMPASS Pathways, and ...

In this article, we will be taking a look at the 13 Best Psychedelic Stocks to Invest in Now. Unlike drugs such as cocaine or marijuana, psychedelics create an “alternate reality” by altering feelings ...

Companies focused on psychedelic medicines indicated a mixed performance on Friday after the U.S. FDA commented on Lykos Therapeutics' marketing application for midomafetamine (MDMA), also known as ...

In contrast to drugs like cocaine or marijuana, psychedelics are strong and give users access to a kind of “alternate reality.” One class of hallucinogenic substances that can produce unusual states ...

A panel of advisors to the Food and Drug Administration (FDA) rejected MDMA as a treatment for post-traumatic stress disorder (PTSD) on Tuesday, citing a lack of evidence that the benefits would ...